FDA Clears Dapagliflozin to Treat Heart Failure With Reduced Ejection Fraction. This was based on data from the DAPA-HF Trial. John McMurray, M.D., presenting the DAPA-HF Trial at AHA 2019 last November. It was part of the late-breaking presentations in the "Outside the Box: New Approaches to CVD Risk Reduction" session. Photo by AHA/Phil McCarten

May 6, 2020 — The U.S. Food and Drug Administration approved AstraZeneca’s dapagliflozin (Farxiga) oral tablets for adults with heart failure with reduced ejection fraction (HFrEF) to reduce the risk of cardiovascular death and hospitalization for heart failure. 

May 6, 2020 — The European Society of Cardiology (ESC), one of the world's largest cardiovascular conferences, is cancelling its in-person meeting and moving to a virtual meeting Aug. 29 through Sept 1, 2020, due to the COVID-19 (SARS-CoV-2) containment efforts.

May 5, 2020 — The large European interventional cardiology conference EuroPCR has been cancelled due to the contenting containment efforts for COVID-19 (SARS-CoV-2).

May 5, 2020 — Children and teenagers with COVID-19 showed distinctive clinical and computed tomography (CT) findings, according to a new study published today in Radiology: Cardiothoracic Imaging.

May 5, 2020 — Wearable biosensor vendor VitalConnect Inc. was granted emergency use authorization (EUA) status by the U.S. Food and Drug Administration (FDA) as part of the response to the COVID-19 pandemic. The FDA EUA will further enhance the capabilities of the VitalPatch and continuous patient monitoring technology, the Vista Solution. 

May 5, 2020 — The Society of Cardiovascular Computed Tomography (SCCT) announced plans  this week to hold its annual scientific meeting in a virtual format. The in-person meeting planned to take place in Seattle, Wash., has been cancelled, due to coronavirus-related restrictions on travel and gatherings as well as concern about the health, well-being and safety of our attendees, faculty and their patients.

May 4, 2020 – A new technique that combines computed tomography (CT) and magnetic resonance imaging MRI can bolster coronary artery disease diagnosis and help to define appropriate treatment for patients suffering from the disease, according to a new study published in the journal Radiology: Cardiothoracic Imaging.

Bilateral pulmonary embolisms seen on spectral CT. Photo courtesy of Siemens Healthineers.

May 4, 2020 — A committee comprised of vascular surgeons, medical physicians and technologists from the University of Michigan has provided an evidence-based algorithm for the treatment for venous thromboembolism (VTE) without confirmatory imaging during the pandemic. The manuscript is available online from the Journal of Vascular Surgery: Venous and Lymphatic Disorders and is freely available on the COVID-19 Collection on the Journal of Vascular Surgery (JVS) website.[1]

May 4, 2020 – The Society for Cardiovascular Angiography and Interventions (SCAI) has released a position statement on adult congenital cardiac interventional training, competencies and organizational recommendations.

May 4, 2020 — Cardiac Insight Inc., a U.S.-based digital healthcare innovator specializing in body-worn sensor technology and automated electrocardiogram (ECG)-analysis software, announced the Heart@Home ECG Test Kit can help address new telehealth demands placed on cardiology practices by the COVID-19 response.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now